Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) announced that Chairman, CEO and President Jim Davis will discuss the company’s strategy, performance and current healthcare market trends at the Baird 2026 Global Healthcare Conference in New York City on Tuesday, September 15, 2026, at 10:50 a.m. Eastern Time. The fireside chat and Q&A will be webcast live via the company’s investor relations site, with an archived replay available within 24 hours and accessible until October 13, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECAUCUS, N.J., Aug. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during the Baird 2026 Global Healthcare Conference in New York City on Tuesday, September 15, 2026, at 10:50 a.m. Eastern Time.

The fireside chat and Q&A session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 13, 2026.

About Quest Diagnostics

Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-baird-2026-global-healthcare-conference-302857720.html

SOURCE Quest Diagnostics

FAQ

When will Quest Diagnostics (DGX) present at the Baird 2026 Global Healthcare Conference?

Quest Diagnostics will present at the Baird 2026 Global Healthcare Conference on Tuesday, September 15, 2026, at 10:50 a.m. Eastern Time. According to Quest Diagnostics, Jim Davis will speak on strategy, performance and healthcare market trends during a fireside chat and Q&A.

Who will represent Quest Diagnostics (NYSE: DGX) at the Baird 2026 Global Healthcare Conference?

Quest Diagnostics will be represented by Jim Davis, the company’s Chairman, CEO and President. According to Quest Diagnostics, Davis will discuss company strategy, performance, and recent healthcare market developments and trends in a fireside chat and Q&A format.

How can investors listen to Quest Diagnostics’ Baird 2026 Global Healthcare Conference webcast?

Investors can access the live webcast on Quest Diagnostics’ investor relations webpage at ir.QuestDiagnostics.com. According to Quest Diagnostics, the fireside chat and Q&A will be streamed live from the conference in New York City for online listeners.

Will a replay of Quest Diagnostics’ Baird 2026 conference presentation be available for DGX shareholders?

Yes, a replay will be available within 24 hours after the live event and remain online until October 13, 2026. According to Quest Diagnostics, the archived webcast can be accessed through the company’s investor relations page.

What topics will Quest Diagnostics cover at the Baird 2026 Global Healthcare Conference?

Quest Diagnostics plans to cover its strategy, performance, and the latest healthcare market developments and trends. According to Quest Diagnostics, Jim Davis will address these areas during a fireside chat followed by a Q&A session for conference attendees and webcast listeners.